<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">A number of approaches are being taken to develop universal influenza vaccines, including the induction of cross-reactive (CD8+) T cells and those that induce antibodies to the head domain of HA.
 <sup>
  <xref ref-type="bibr" rid="CR61">61</xref>
 </sup> Novel antigen delivery systems and vaccination strategies include the use of CpG-adjuvanted peptide vaccines to provide heterosubtypic protection by inhibiting regulatory T cell (Treg) development, thus enhancing T-cell immunity.
 <sup>
  <xref ref-type="bibr" rid="CR62">62</xref>
 </sup>
</p>
